Summary Recently. apoptosis has been implicated as one of the end points of cells exposed to chemotherapeutic agents. The p53 and Bcl-2 family of proteins are involved in chemotherapy-induced apoptosis. but in a cell type-dependent manner. We sought to determine the roles played by the p53 and Bcl-2 family of proteins in 5-fluorouracil (5-FU)-induced apoptosis of human colon cancer cell lines. We first studied the p53 genetic and functional status, and then 5-FU, at inhibitory concentration of 50% (ICj) 
drui-target interaction and its consequent sequelae (Inaba et al. 1990 : Aschele et al. 1992 : Beck et al. 1994 ). More recentlv. the pattern and extent of cell damage induced by chemotherapeutics. for example fluoropyrimidines. in human cancer cells have been suggested to depend also on pathwas as downstream from drug-target interactions that. once trigaered. will initiate programmed cell death (apoptosis) (Canman et al. 1992 : Fisher et al. 1993 : Lowe et al. 1993 ). For example. a human colon cancer cell line (HT29) has recently been reported to be induced to apoptosis by 5-FLT (Piazza et al. 1997) . The wside vafietv of currently available drugs. with disparate mechanisms of actions leading to the same mode of cell death. supports this proposal (Dive and Hickman. 1991) .
In vitro and in vivo experiments have sugagested the involvement of the p53 and Bcl-2 family in chemotherapy-induced apoptosis (Harris. 1996: Yangy and . The tumour-suppressor p53 is involsed in the control of cell growth. arrest and apoptosis Received 22 October 1997 Revised 4 February 1998 Accepted 31 March 1998 Correspondence to: H Nagawa. First Department of Surgery. The University of Tokyo Hospital. 7-3-1 Hongo. Bunkyo-ku. Tokyo 113. Japan (Enoch and Norbur-. 1995) . Cells exposed to a DNA-damaging agent will activate wsild-type p53 (wt-p53) and the cell can then either arrest at G, and be repaired or undergo apoptosis (Guillouf et al. 1995) : shichever of these options predominates might reflect the relative levels of p2l1"IF' (Poly-ak et al. 1996) and/or bcl-2 family expression. How-ever. p53-defectisve cells also show apoptosis induction after exposure to DNA-damaging agents. suggoesting the importance of alternative pathw ay s inducinc apoptosis after DNA damage (Dou et al. 1995) .
Bcl-2 is a member of a g rosing family of apoptosis regulators. Bcl-2 and Bcl-XL can block cell death in various cell systems under a variety of conditions. For example. forced Bcl-2 overexpression in lymphoid (Miyashita and Reed. 1992) or leukaemic (Miyashita and Reed. 1993) (Strobel et al. 1996) enhanced the apoptotic response to antineoplastic drugs. as has been observed in breast cancer cell lines (Sakakura et al. 1996) .
Thus. although apoptosis has emerged as a nosvel potential mechanism of druc resistance. it appears to vary according to the cell ts pe and the triggering stimulus. We designed this study to gain further insights into the effect of 5-FLT in human colon cancer cell lines (CCCLs) by studying the Bcl-2 family response to this agent and its correlation with p53 status. (Bosanquet. 1989) . Furthermore. others have sugaested different mechanisms of 5-FL action depending on the duration of 5-FU exposure. i.e. a DNA-directed effect is observed w-hen cells are continuously exposed for a relatixely long time (Inaba et al. 1990 : Aschele et al. 1992 ). We confirmed this to be the case in our preliminarys experiments. All the experiments w-ere performed using the floating and attached cells. The cells wAere cultured in either the absence or the presence of 5-FL using IC, (equitoxic doses) for 3 consecuti'e days. and cell morphology was then studied by staininc the cells w-ith acridine orange (AO) (5 go, ml-'. Sigma. Saint Louis. MO. USA) as described elsew here (Gregory et al. 1991 ) and obserned by fluorescence microscopy. Cells designated as apoptotic wxere those that displaved the characteristic morphological features of apoptosis. includine cell s-olume shrinkage. condensed chromatin and fragmented nuclei. compared with non-apoptotic cells (Kerr et al. 1994 ). Apoptosis was confirmed by 'Cell Death' Detection ELISAP'5-u (Boehringer Mannheim. Mannheim. Germanv). w-hich measures cVtoplasmic DNA-histone complexes aAccording to the present and previous studies (Baker et al. 1990 : Rodrigues et al. 1990 ). cUp-regulation of p2lwAF1. as determined by Westem blotting performed as described in Materials and methods. after exposure of these cell lines to 5-FU (ICSo) for 48 h. c1CO: inhibitory concentration of 50O is defined as the drug concentration necessary to inhibit 50°o of cell growth compared with untreated controls. IC was calculated by MTT assay, after 72 h of continuous incubation with 5-FU. Each experiment was performed in four replicate wells and the results are the means ± s.d. of three independent experinents. 'Not statistically significant. generated during apoptotic DNA fragmentation. W'e measured the level of apoptotic cells and compared this with untreated control cells to confirm a higher level of apoptosis in the treatment group.
In our preliminarv experiments. different numbers of cell equivalents were used to determine the optimal conditions. CCCLs were exposed to equitoxic (IC,,,) doses of 5-FUT for 72 h and cytoplasmic extracts of the equivalent of lxlO cells were used in the enzvmelinked immunosorbent assav (ELISA) performed accordinc to the manufacturer's specifications.
Polymerase chain reaction (PCR) amplification and DNA sequencing
Exons 4-8 of the p53 gene w-ere amplified from genomic DNA. using primer sequences described elsew-here (Lehman et al. 1991 Korsmeyer. 1994: Yang and . A recent report demonstrated that high levels of Bcl-2 or Bcl-X, proteins are equally effective in terms of inhibiting apoptosis and suggest that the differences in their ability to block apoptosis may be due to different levels of protein expression (Huang et al. 1997 Another finding of our experiments was that Bcl-X,L was predominantly expressed at steady-state levels in all of these cell lines other than Colo320 (Fiaure 2). and a slight increase in Bcl-X, expression was observed in DLD1 after exposure to 5-FU ( Figure  4D Figure 3 . y-0.084 + 0.071 x x (F = coefficiet of determiati) expression of Bcl-XL rather than Bcl-2, has already been demonstrated using neuroblastoma cancer cell lines (Dole et al, 1995) . resistant murine leukaemic cells (Kuhl et al, 1997 ) and non-smallcell lung cancer cell lines (Reeve et al, 1996) . However, to our knowledge, this is the first such demonstration using CCCLs.
Given that Bcl-XL may suppress cell death in the same way as Bcl-2, the functional redundancy between these apoptosis inhibitors may compensate for the absence of Bcl-2 by producing Bcl-XL instead. In addition, forced expression of p53 activity, by transfection of a temperature-sensitive mutant p53 into HT29 cells, induced Bax and Bcl-XL expression rather than Bcl-2 (Merchant et al, 1996) . These data suggest that these CCCLs illustrate Bcl-XLrelated drug resistance to apoptosis. In support of these in vitro experinmental results. a shift from Bcl-2 to the increased expression of Bcl-XL has been reported in vivo from colorectal adenoma to adenocarcinoma (Krajewska et al. 1996) . p53 regulation does not appear to control cellular sensitivity to apoptosis in CCCLs. Some reports have described p53-dependent apoptosis as being induced by various chemotherpeutic compounds in different cell types, including gastric and ovarian cancer cell lines (Nabeya et al, 1995; Perego et al, 1996) . However, herein we have shown that CCCLs exposed to 5-FU undergo apoptosis in mutant as well as in wt-p53 (Table 1) , confirming previous reports of p53-independent regulation of apoptosis in colon cancer (Bracey et al, 1995) .
Knowledge of the capacity of p53 to induce apoptosis in a given cell system may be important for designing new strategies involving agents that restore the wt-p53 function. In these cell lines, however. such a strategy might not be the best choice because 5-FU induced apoptosis independently of p53 status. Rather, alternatives that reduce a given threshold for triggering apoptosis may be another option. For example. antisense oligonucleotides targeting Bcl-XL function coupled with chemotherapyinduced apoptosis might effectively increase the potency of drug-based therapy.
In conclusion, the roles of the Bcl-2 family proteins as apoptosis regulators in 5-EU treatment suggest that they may be useful as novel treatment targets, as well as serving as treatment response markers and consequently as prognostic factors.
